Weaver Capital Management’s Eli Lilly LLY Stock Holding History

Weaver Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.26M	Buy	6,804 +328	+5%	+$333K	1.36%	21
2025 Q4	$6.96M	Buy	6,476 +1,023	+19%	+$978K	1.47%	17
2025 Q3	$4.16M	Buy	5,453 +1,864	+52%	+$1.39M	0.9%	31
2025 Q2	$2.8M	Buy	3,589 +104	+3%	+$80.8K	0.68%	35
2025 Q1	$2.88M	Buy	3,485 +1,143	+49%	+$951K	0.76%	32
2024 Q4	$1.81M	Buy	2,342 +580	+33%	+$480K	0.5%	53
2024 Q3	$1.56M	Sell	1,762 -18	-1%	-$16.2K	0.47%	63
2024 Q2	$1.61M	Buy	1,780 +472	+36%	+$378K	0.52%	58
2024 Q1	$1.02M	Sell	1,308 -10	-0.8%	-$7.12K	0.35%	81
2023 Q4	$768K	Buy	+1,318	New	+$769K	0.3%	83

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Weaver Capital Management's LLY Position: Q1 2026 in Review

Weaver Capital Management increased its Eli Lilly (LLY) stake by 5.1% in Q1 2026, buying an estimated $333K and bringing the position to 6,804 shares worth $6.26M. The position accounts for 1.36% of the portfolio, ranked #21.

Weaver Capital Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.96M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Weaver Capital Management held 6,804 shares of Eli Lilly worth $6.26M as of Q1 2026.
Weaver Capital Management bought 328 Eli Lilly shares in Q1 2026, an estimated $333K.
Eli Lilly made up 1.36% of Weaver Capital Management's portfolio in Q1 2026, its #21 holding.
Weaver Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
Weaver Capital Management's Eli Lilly position peaked at $6.96M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Weaver Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.